Mr Seni Mylvaganam is a Consultant Oncoplastic Breast Surgeon, who specialises in the surgical assessment and management of breast symptoms and benign disease, breast cancer and breast reconstruction. He also has expertise in the practice of cosmetic breast surgery.
Seni initially qualified as a doctor in 2003, at the Royal Free and University College London Medical School, prior to which he completed his Bachelor's degree in Pharmacology at University College London. After completing his medical degree, he completed his specialist training with the National Oncoplastic Breast fellowship. The fellowship is restricted by competition to a select few breast and plastic surgeons each year. It is regarded as the gold standard for breast reconstructive training in the UK.
After completing his specialist registrar training, he was appointed as Consultant Oncoplastic Breast surgeon at the Royal Wolverhampton Hospitals NHS Trust. He also holds the role of professional clinical advisor in surgery to the NHS Breast screening programme. He is a member of the Association of Breast Surgery Clinical Practice and Standards Committee, part of the board who are responsible for UK national breast surgery practice standards.
Seni Mylvaganam - “I aim to provide every patient with the highest quality assessment, advice and treatment whether this is regarding benign breast symptoms, breast cancer care or cosmetic considerations. My patients are at the heart of this process and understanding their needs is essential to offering the best treatment tailored to each individual”.
MUMS offers a range of Breast Cancer Screening Services
Breast cancer is the most common cancer in women with an incidence of 1 in 8 at 80y/o, 1 in 50 at 50y/o and 1 in 2500 at 30 y/o.
However, the vast majority of patients referred or self-referred with breast symptoms do not have a malignant diagnosis. NHS England data suggests that a dedicated NHS breast fast track clinic will see between 12-20 patients before diagnosing 1 cancer. That number needed to see significantly increases when the patients are aged <40 y/o.
The aim of a breast reassurance clinic is to provide women with fast direct access to an expert breast specialist to evaluate their symptoms and provide a prompt, clear, detailed explanation and diagnosis for each woman. Find out more about our breast cancer ultrasound scan tests here.
Genomic medicine (the use of a person’s individual DNA to inform about disease risk and how to treat) is increasingly playing a central part in how we view and treat breast cancer. It can enable us to identify individuals at a higher risk of developing breast cancer so a person can know their risk but also what to do with that information to reduce their risk. Learn more about our Breast Cancer gene testing here.